Poland· PL-100234887

Zulbex

A rabeprazole product containing rabeprazolum natricum, registered in Poland by Krka, d.d., Novo mesto. The same ATC class is registered in 17 of our 19 countries.

ATC A02BC04

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedZulbexATCA02BC04REGISTER NO.PL-100234887PACKS LISTED4CHECKEDSeptember 27, 2026

Where it is registered

Rabeprazole is registered in 17 of 19 countries.

Countries holding a registration under ATC A02BC04 (rabeprazole), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 10 of them publish a price we can compare per daily dose

Rabeprazole · ATC A02BC04

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of rabeprazole costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.13 in France to $0.85 in Switzerland — a ×6.4 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Rabeprazole · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.85
  • ES Spain$0.50
  • IT Italy$0.24
  • FR France$0.13
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Rabeprazolum natricum
Manufacturer
Krka, d.d., Novo mesto
Country
Poland (PL)
ATC code
A02BC04
ATC class
Rabeprazole
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909990813902
  • gtin
    05909990813933
  • gtin
    05909991185855
  • gtin
    05909991185862

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

592 interactions on record for rabeprazole.

Graded by severity as the source publishes them — 22 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Rabeprazole · interactions on record

592 records

  • 22 severe
  • 107 moderate
  • 27 minor
  • 427 info

Most severe, free to view

  • ClopidogrelB01AC04severe
  • NelfinavirJ05AE04severe
  • AtazanavirJ05AE08severe
  • RilpivirineJ05AG05severe

9 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Rabeprazole in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rabeprazole products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Pariet, Rabeprazol 1a Pharma
  • Belgium · Pariet
  • Bulgaria · Ацилесол, Зулбекс
  • Cyprus · Pariet, Rabeprazole Krka
  • Czechia · Rapoxol, Zulbex
  • Germany · Pariet, Rabeprazol Puren
  • Denmark · Pariet, Rabeprazol Medical Valley
  • Estonia · Rabeprazole Actavis, Rabeprazole Doc Generici
  • Spain · Pariet, Rabeprazol Almus
  • Finland · Pariet, Rabeprazol Krka
  • France · Pariet, Rabeprazole Almus
  • United Kingdom (Northern Ireland) · Pariet, Rabeprazole Accord Healthcare
  • Greece · Aircodos, Berlex
  • Croatia · Ares, Zulbex
  • Hungary · Acilesol, Gelbra
  • Ireland · Pariet, Rabeprazole Krka
  • Iceland · Pariet, Rabeprazol Actavis
  • Italy · Akirab, Pariet
  • Lithuania · Rabeprazole Actavis, Yzilan
  • Luxembourg · Pariet
  • Latvia · Rabeprazole Adoh, Zulbex
  • Malta · Pariet
  • Netherlands · Beryx, Pariet
  • Portugal · Pariet, Rabeprazol Aurovitas
  • Romania · Relitaz, Zulbex
  • Sweden · Pariet
  • Slovenia · Rabeprazol Lek, Zulbex
  • Slovakia · Zulbex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2abd0211-042b-4286-b9f8-c2dfe27ddd24
GET /v1/drugs/2abd0211-042b-4286-b9f8-c2dfe27ddd24?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki dojelitowe",
  "source": "urpl",
  "strength": "20 mg",
  "packaging": "05909990813902 ¦ Rp ¦ 61309\n14 tabl.\n05909990813933 ¦ Rp ¦ 61310\n28 tabl.\n05909991185855 ¦ Rp ¦ 103324\n7 tabl.\n05909991185862 ¦ Rp ¦ 103325\n56 tabl.",
  "substance": "Rabeprazolum natricum 20 mg",
  "common_name": "Rabeprazolum natricum",
  "pl_product_id": "100234887",
  "pozwolenie_nr": "17419",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

See everything about rabeprazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.